TAT Technologies Posts Upbeat Q1 Earnings, Joins Roivant Sciences, Immunitybio And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Wednesday.

Shares of TAT Technologies Ltd (NASDAQ:TATT) rose sharply after the company reported better-than-expected first-quarter financial results.

TAT Techs posted quarterly earnings of 26 cents per share, beating market estimates of 19 cents per share. The company's sales came in at $41.147 million topping estimates of $40.400 million.

TAT Technologies shares jumped 11.7% to $36.52 on Wednesday.

Here are some other big stocks recording gains in today’s session.

• Immunovant Inc (NASDAQ:IMVT) shares jumped 22.2% to $32.12 following fourth-quarter results.
• Sellas Life Sciences Group Inc (NASDAQ:SLS) gained 17.6% to $8.92 as traders react to the company’s latest update on its acute myeloid leukemia pipeline and the timeline for a pivotal Phase 3 readout.
• T1 Energy Inc (NYSE:TE) gained 17% to $8.05.
• Vuzix Corp (NASDAQ:VUZI) rose 12.2% to $4.61.
• Roivant Sciences Ltd (NASDAQ:ROIV) gained 12.2% to $31.64 after the company reported better-than-expected fourth-quarter adjusted EPS results.
• POET Technologies Inc (NASDAQ:POET) shares jumped 11.5% to $14.58.
• Arm Holdings PLC – ADR (NASDAQ:ARM) shares gained 11.3% to $248.40.
• AMC Entertainment Holdings Inc (NYSE:AMC) rose 10.3% to $1.50. CEO Adam Aron disclosed in a Form 4 filed after Tuesday’s close that he bought 250,000 shares in multiple transactions at an average price of about $1.38, lifting his total ownership to roughly 2.44 million shares.
• Astera Labs, Inc (NASDAQ:ALAB) gained 9.8% to $268.26.
• Design Therapeutics Inc (NASDAQ:DSGN) jumped 9.2% to $11.45.
• Talen Energy Corp (NASDAQ:TLN) gained 8.6% to $341.88. Daniel Kelly joined Talen as general counsel and corporate secretary.
• Synaptics Inc (NASDAQ:SYNA) rose 8.4% to $134.00. Rosenblatt analyst Kevin Cassidy maintained Synaptics with a Buy and raised the price target from $125 to $180.
• Marvell Technology Inc (NASDAQ:MRVL) rose 7.2% to $188.90. Wells Fargo analyst Aaron Rakers maintained Marvell Technology with an Overweight rating and raised the price target from $135 to $195.
• Astronics Corp (NASDAQ:ATRO) gained 7.1% to $85.00.
• Immunitybio Inc (NASDAQ:IBRX) rose 7.1% to $8.31 after the company announced that the FDA accepted for review the supplemental Biologics License Application for ANKTIVA in combination with Bacillus Calmette-Guerin for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer with papillary disease without carcinoma in situ.
• Intel Corp (NASDAQ:INTC) rose 5.4% to $116.77.

Photo via Shutterstock